EGFR and colorectal carcinoma: These genetic alterations that can be observed in CRC promote the activation of signalling pathways that are involved in survival, cell proliferation and cell-cycle progression; the two main pathways that are altered in CRC are Epidermal Growth Factor Receptor-Reticular Activating System (EGFR-RAS) and Wnt-β-catenin pathways [4].